VR Logo

Glaxosmithkline Pharmaceuticals Ltd.


Healthcare | Drugs & Pharma

we think vacations are for wimps

38 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Manufacture of allopathic pharmaceutical preparations

Incorporated: 1924

Chairman: R S Karnad

Managing Director: A Vaidheesh

Group: Glaxosmithkline - MNC

Listing: NSE: GLAXO, BSE: 500660

Headquarters: Mumbai, Maharashtra

Website: www.gsk-india.com

Key Facts

Market cap: R 28,592.35 Cr

Revenue (TTM): R 3,246.69 Cr

Earnings (TTM): R 852.25 Cr

Cash: R 1,171.35 Cr

Total Debt: R 0.58 Cr

Promoters' ownership: 75.00%

Liquidity: High

52 Week range: R 1,130.00 - 1,737.00

Face value: R10.00

Shares outstanding: 16,94,06,034

Stock Performance

Time Period Glaxosmithkline Pharma S&P BSE Mid Cap S&P BSE Healthcare
YTD4.734.746.31
1 month4.235.016.41
3 months8.738.569.95
1 Year21.098.794.53
3 Years7.126.53-1.59
5 Years-0.107.72-1.73
10 Years8.259.2911.62
As on 28-Jan-2020
Year Glaxosmithkline Pharma S&P BSE Mid Cap S&P BSE Healthcare
20197.50-3.05-3.55
201821.62-13.31-5.89
2017-8.8148.130.49
2016-17.157.97-12.88
20154.557.4315.06
20146.9654.6947.43
201339.74-5.7322.55

Review & Analysis